Simplex Trading
PSTX

Simplex Trading’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Simplex Trading’s Portfolio PSTX Stock Details PSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-14,032
Closed -$134K – 10032
2024
Q4 		$134K Buy
+14,032
New +$73.2K ﹤0.01% 4913
2024
Q3 		– Sell
-1,335
Closed -$4.13K – 9829
2024
Q2 		$3K Buy
+1,335
New +$3.65K ﹤0.01% 8199
2024
Q1 		– Sell
-6,588
Closed -$22K – 10161
2023
Q4 		$22K Buy
+6,588
New +$17K ﹤0.01% 6862
2023
Q3 		– Sell
-157
Closed -$329 – 10097
2023
Q2 		$0 Sell
157
-453
-74% -$1.16K ﹤0.01% 10179
2023
Q1 		$1K Buy
+610
New +$3.66K ﹤0.01% 8820
2022
Q2 		– Sell
-120
Closed -$334 – 11354
2022
Q1 		$0 Buy
+120
New +$541 ﹤0.01% 11601
2021
Q4 		– Sell
-181
Closed -$1.23K – 11666
2021
Q3 		$1K Buy
181
+100
+123% +$858 ﹤0.01% 9696
2021
Q2 		$0 Buy
+81
New +$725 ﹤0.01% 10856
2021
Q1 		– Sell
-100
Closed -$981 – 10268
2020
Q4 		$1K Buy
+100
New +$1.05K ﹤0.01% 8181

Other funds holding PSTX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Simplex Trading's PSTX Position: Q1 2025 in Review

Simplex Trading sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 14,032 shares — an estimated $134K sold.

Simplex Trading first reported a position in PSTX in Q4 2020 and held it in 9 quarters. The position peaked at $134K in Q4 2024. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

  • Simplex Trading reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Simplex Trading sold 14,032 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $134K.
  • Simplex Trading first reported a position in Poseida Therapeutics, Inc. Common Stock in Q4 2020 and held it in 9 quarters.
  • Simplex Trading's Poseida Therapeutics, Inc. Common Stock position peaked at $134K in Q4 2024.
  • 1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.